Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Methylation of MYLK3 gene promoter region: a biomarker to stratify surgical care in ovarian cancer in a multicentre study

28 Mar 2017

Abstract excerpt

BACKGROUND: Survival benefit from surgical debulking of ovarian cancer (OC) is well established, but some women, despite total macroscopic clearance of disease, still have poor prognosis. We aimed to identify biomarkers to predict benefit from conventional surgery. METHODS: Clinical data from women debulked for high-stage OC were analysed (Hammersmith Hospital, London, UK; 2001-2014). Infinium's...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromatin Remodeling and Cancer
Share to Ferroptosis and cancer prognosis
Share to Ovarian cancer diagnosis and treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28350786
DOI: 10.1038/bjc.2017.83

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Methylation of MYLK3 gene promoter region: a biomarker to stratify surgical care in ovarian cancer in a multicentre studyPMID 28350786Read ↗

Methylomic Analysis of Ovarian Cancers Identifies Tumor-Specific Alterations Readily Detectable in Early Precursor LesionsSemantic proximity Read ↗

Genome-scale screen for DNA methylation-based detection markers for ovarian cancer.Semantic proximity Read ↗

The discovery and evaluation of treatment stratification biomarkers in epithelial ovarian cancerSemantic proximity Read ↗

Biostatistical analysis of DNA methylation profiling in ovarian cancerSemantic proximity Read ↗

The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancerSemantic proximity Read ↗

Methylome analysis of extreme chemoresponsive patients identifies novel markers of platinum sensitivity in high-grade serous ovarian cancerSemantic proximity Read ↗

DNA methylation profile in CpG-depleted regions uncovers a high-risk subtype of early-stage colorectal cancerSemantic proximity Read ↗

[Prognostic stratification value of MLH1 promoter methylation in endometrioid endometrial carcinomas with a dMMR molecular phenotype].Semantic proximity Read ↗

Molecular Classification of Epithelial Ovarian Cancer Based on Methylation Profiling: Evidence for Survival HeterogeneitySemantic proximity Read ↗

RUNX3 and CAMK2N1 hypermethylation as prognostic marker for epithelial ovarian cancerSemantic proximity Read ↗

Emerging LncRNA HOTAIR and NME1 polymorphisms in ovarian cancer risk: A pilot case-control study in South Indian women.Semantic proximity Read ↗

Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.